« Back to Farmacia Journal 1/2016
ANTICANCER EFFECTS OF CO-ADMINISTRATION OF DAUNORUBICIN AND RESVERATROL IN MOLT-4, U266 B1 AND RAJI CELL LINES
HMOUD HASHEMZAEI1, SAEED PUDINE KARAMI1, AMIN DELARAMIFAR1, ALIREZA SHEIDARY1, KAVEH TABRIZIAN1,2, RAMIN REZAEE3, SHABNAM SHAHSAVAND3, ANDREEA LETIȚIA ARSENE4, ARISTIDIS MICHAEL TSATSAKIS5, SEYED MOHAMMAD TAGHDISI6*
1.Department of Pharmacology and Toxicology, Faculty of Pharmacy, Zabol University of Medical Sciences, Zabol, Iran
2 .Medicinal Plants Research Center, Zabol University of Medical Sciences, Zabol, Iran
3 .Department of Physiology and Pharmacology, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran
4 .Department of Biochemistry, Faculty of Pharmacy, “Carol Davila” University of Medicine and Pharmacy, 6, Traian Vuia Street, sector 2, Bucharest, Romania
5 .Department of Forensic Sciences and Toxicology, Faculty of Medicine, University of Crete, Heraklion 71003, Greece
6 .Department of Pharmaceutical Biotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran